Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation
Open Access
- 1 August 2006
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (8) , 2105-2114
- https://doi.org/10.1172/jci27180
Abstract
The CD18 hypomorphic (CD18hypo) PL/J mouse model clinically resembling human psoriasis is characterized by reduced expression of the common chain of β2 integrins (CD11/CD18) to only 2–16% of WT levels. Previously we found that this chronic psoriasiform skin inflammation also depends on the presence of CD4+ T cells. Herein we investigated the role of macrophages in this CD18hypo mouse model. Activated macrophages were significantly increased in lesional skin as well as in inflamed skin draining lymph nodes (DLNs) of affected CD18hypo mice and were identified as being an important source of TNF-α in vivo. Both depletion of macrophages and neutralization of TNF-α resulted in a significant alleviation of psoriasiform skin inflammation. As monocyte chemotactic protein 1 was enhanced in lesional skin of affected CD18hypo mice, we intradermally injected recombinant murine monocyte chemotactic protein-1 (rJE/MCP-1) alone or in combination with rTNF-α into the skin of healthy CD18hypo mice. Only simultaneous injection of rJE/MCP-1 and rTNF-α, but neither substance alone, resulted in the induction of psoriasiform skin inflammation around the injection sites with recruitment and activation of macrophages. Collectively, our data suggest that maintenance of psoriasiform skin inflammation critically depends on efficient recruitment and activation of macrophages with sufficient release of TNF-α.Keywords
This publication has 59 references indexed in Scilit:
- Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammationJournal of Clinical Investigation, 2006
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature, 2005
- PsoriasisNew England Journal of Medicine, 2005
- Anti-TNF-α therapies: the next generationNature Reviews Drug Discovery, 2003
- Betamethasone Valerate in Foam Vehicle Is Effective with Both Daily and Twice a Day Dosing: A Single-Blind, Open-Label Study in the Treatment of Scalp PsoriasisJournal of Cutaneous Medicine and Surgery, 2001
- Keratinocyte-Derived Monocyte Chemoattractant Protein 1 (MCP-1): Analysis in a Transgenic Model Demonstrates MCP-1 Can Recruit Dendritic and Langerhans Cells to SkinJournal of Investigative Dermatology, 1995
- Anti-CD4 monoclonal antibody therapy in severe psoriasisJournal of Autoimmunity, 1992
- Tumor necrosis factorJournal of the American Academy of Dermatology, 1991
- Integrins: A family of cell surface receptorsCell, 1987
- Psoriatic AlopeciaBritish Journal of Dermatology, 1972